NYSE$STE

STERIS PLC · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

STERIS's first quarter results reflected a balanced business model and were impacted by reduction in deferrable procedures, with revenue declining and net income growing.

STERIS plc reported a 4% decrease in revenue to $668.9 million, driven by declines in Healthcare and Applied Sterilization Technologies, offset by growth in Life Sciences. Net income increased to $88.2 million, or $1.03 per diluted share, compared to $84.6 million, or $0.99 per diluted share in the previous year.

  • First quarter revenue declined low-single digits due to reduction in deferrable procedures.
  • First quarter net income grew low-single digits driven by margin expansion.
  • Healthcare segment was most impacted by the reduction of deferrable procedures, with revenue declining 10%.
  • Life Sciences segment continued its strong performance, with revenue growing 21%.

Headline financials

Total Revenue

$669M

Previous: $697M-4.0%
EPS (adj)

$1.31

Previous: $1.23+6.5%
Const. Curr. Organic Growth

-3.4%

No prior period
Capital Expenditures

-$66.9M

Previous: -$49.8M-34.3%
Free Cash Flow

$67.3M

Previous: $59.5M+13.0%
Net Income

$88.2M

Previous: $84.6M+4.3%
Operating Income

$114M

Previous: $110M+3.6%
Gross Profit

$286M

Previous: $306M-6.6%
Cash & Equivalents

$256M

Previous: $238M+7.4%
Total Assets

$5.36B

Previous: $5.23B+2.6%
Stock-Based Comp

$5.96M

Previous: $5.54M+7.7%

Revenue & EPS history

STERIS · Revenue · Quarterly

$669M

Q1 2021-4%vs Q1 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

STERIS · $1.59B total across 3 segments · Q4 2027

  • Healthcare
    $1.14B
  • Applied Sterilization Technologies
    $289M
  • Life Sciences
    $163M

Forward guidance

Due to the continuing uncertainty, STERIS is not providing guidance for fiscal year 2021.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+0.5%

Avg return

Earnings day

+1.0%

Avg return

5 days after

+1.3%

Avg return

30 days after

59%

38 / 64 earnings

Positive

+12.9%

Q4 2014

Best reaction

-11.4%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2027+0.0%+7.2%+2.8%
Q3 2026-7.7%-7.4%-12.8%
Q2 2026+7.0%+9.7%+8.3%
Q4 2025+8.6%+10.1%+6.1%
Q3 2025+2.1%+1.1%+5.4%
Q2 2025-5.2%-2.5%-5.1%
Q1 2025-1.8%-0.8%+0.5%
Q4 2024+6.2%+9.2%+6.6%
Q3 2024-2.5%-0.4%+3.4%
Q2 2024-5.1%-8.4%-7.1%
Q1 2024+1.0%+0.2%+1.8%
Q4 2023+11.2%+12.7%+10.6%
Q3 2023-11.4%-9.5%-18.2%
Q2 2023+3.5%+2.6%+17.3%
Q1 2023-8.8%-4.7%-10.0%
Q4 2022+1.4%+1.2%+2.6%
Q3 2022+4.6%+1.3%-2.1%
Q2 2022-5.5%-4.8%-6.4%
Q1 2022+0.6%+1.2%+0.2%
Q4 2021-3.6%-3.1%+1.9%
Q3 2021-1.9%-1.7%-8.1%
Q2 2021-0.5%+2.5%+8.8%
Q1 2021-1.0%-3.4%+2.5%
Q4 2020+1.2%+7.0%+1.8%
Q3 2020+6.1%+10.2%-5.0%
Q2 2020+2.3%+2.6%+8.4%
Q1 2020+3.0%+4.1%+3.0%
Q4 2019+1.1%+3.2%+10.2%
Q3 2019+1.9%+3.1%+3.6%
Q2 2019+7.0%+7.4%+5.4%
Q1 2019-0.7%-1.1%-1.9%
Q4 2018+4.7%+4.6%+8.6%
Q3 2018-4.7%-2.8%+7.8%
Q2 2018-6.0%-6.6%-3.9%
Q1 2018+4.9%+3.3%+5.8%
Q4 2017+1.4%-0.4%+6.4%
Q3 2017-6.5%-5.7%-3.4%
Q2 2017-3.0%+0.5%-2.0%
Q1 2017-1.6%-1.9%-2.0%
Q4 2016-0.5%
Q3 2016-1.9%
Q2 2016+6.4%
Q1 2016+0.7%
Q4 2015+2.5%
Q3 2015+1.1%
Q2 2015+3.5%
Q1 2015+0.3%
Q4 2014+12.9%
Q3 2014+0.5%
Q2 2014-3.6%
Q1 2014-3.6%
Q4 2013+8.3%
Q3 2013+1.4%
Q1 2013+1.4%
Q2 2013+1.1%
Q4 2012-0.3%
Q3 2012+0.8%
Q1 2012+0.8%
Q2 2012-4.4%
Q4 2011+0.3%
Q3 2010+0.2%
Q1 2010+0.2%
Q2 2010+0.8%
Q4 2010-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro